Traci Rieckmann

Dr. Traci Rieckmann


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
TRTraci Rieckmann
Traci Rieckmann
MDMarilyn Daley
Marilyn Daley
BFBret E. Fuller
Bret E. Fuller
CTCindy P. Thomas
Cindy P. Thomas
DMDennis McCarty
Dennis McCarty

29 August 2012 in The American Journal of Drug and Alcohol Abuse
Verified
Journal Article
Closed access
PDF file
TRTraci Rieckmann
Traci Rieckmann
DMDennis McCarty
Dennis McCarty
AKAnne Kovas
Anne Kovas
PSPaul Spicer
Paul Spicer
JBJoe Bray
Joe Bray
JMJacqueline Mercer
Jacqueline Mercer
Background: American Indians and Alaska Natives (AI/ANs) experience significant disparities in health status and access to care. Furthermore, only limited data are available on substance use, mental health disorders, and treatment needs for this population. Addressing such disparities and developing culturally relevant, effective interventions for AI/AN communities require participatory research. Objectives and Methods: The Western States Node of the National Institute on Drug Abuse Clinical Trials Network partnered with two American Indian substance abuse treatment programs: an urban health center and a reservation-based program to assess client characteristics, drug use patterns, and treatment needs. Data collected by staff members at the respective programs from urban (n = 74) and reservation (n = 121) clients were compared. Additional sub-analysis examined patients reporting regular opioid use and mood disorders. Results: Findings indicate that urban clients were more likely to report employment problems, polysubstance use, and a history of abuse. Reservation-based clients reported having more severe medical problems and a greater prevalence of psychiatric problems. Clients who were regular opioid users were more likely to report having a chronic medical condition, suicidal thoughts, suicide attempts, polysubstance abuse, and IV drug use. Clients who reported a history of depression had twice as many lifetime hospitalizations and more than five times as many days with medical problems. Conclusions: Findings from this project provide information about the patterns of substance abuse and the importance of comprehensive assessments of trauma and comorbid conditions. Results point to the need for integrative coordinated care and auxiliary services for AI/AN clients seeking treatment for substance use disorders.

1 November 2004 in Cultural Diversity & Ethnic Minority Psychology
Verified
Journal Article
Closed access
TRTraci Rieckmann
Traci Rieckmann
MWMartha E. Wadsworth
Martha E. Wadsworth
DDDonna Deyhle
Donna Deyhle
This study investigated the interrelationships among cultural identity, explanatory style, and depression in Navajo adolescents. A total of 332 (197 female, 135 male) Navajo adolescents completed 7 self-report measures. These data were used to create, via structural equation modeling, a series of factor models and full structural models. Analyses indicated that current factor structures for explanatory style and depression are adequate for use with Navajo adolescents. Increased control and predictability and limited duration of stressful encounters were both predictive of decreased symptoms of depression. Higher levels of Navajo cultural identity had a modest effect in terms of reducing depression. Other factors, such as perceived discrimination and urban/reservation domicile, are important to study to provide an increased understanding of depression among Navajo adolescents.

10 June 2008 in The Journal of Behavioral Health Services & Research
Verified
Journal Article
Closed access
PDF file
TRTraci Rieckmann
Traci Rieckmann
AKAnne E. Kovas
Anne E. Kovas
HFHolly E. Fussell
Holly E. Fussell
NSNicole M. Stettler
Nicole M. Stettler

1 December 2011 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
TRTraci Rieckmann
Traci Rieckmann
AKAnne E. Kovas
Anne E. Kovas
BMBentson H. McFarland
Bentson H. McFarland
AAAmanda J. Abraham
Amanda J. Abraham

24 May 2016 in Substance Abuse
Verified
Journal Article
Closed access
TRTraci Rieckmann
Traci Rieckmann
JMJohn Muench
John Muench
MMMary Ann McBurnie
Mary Ann McBurnie
MLMichael C. Leo
Michael C. Leo
PCPhillip Crawford
Phillip Crawford
CNChristine Nelson
Christine Nelson
Background: The Affordable Care Act increases access to treatment services for people who suffer from substance use disorders (SUDs), including alcohol use disorders (AUDs) and opioid use disorders (OUDs). This increased access to treatment has broad implications for delivering health services and creates a dramatic need for transformation in clinical care, service lines, and collaborative care models. Medication-assisted treatments (MAT) are effective for helping SUD patients reach better outcomes. This article uses electronic health record (EHR) data to examine the prevalence of EHR-documented SUDs, patient characteristics, and patterns of MAT prescribing and screening for patients within the Community Health Applied Research Network (CHARN), a national network of 17 community health centers that facilitates patient-centered outcomes research among underserved populations. Methods: Hierarchical generalized linear models examined patient characteristics, SUD occurrence rates, MAT prescription, and human immunodeficiency virus (HIV) and hepatitis virus C screening for patients with AUDs or OUDs. Results: Among 572,582 CHARN adult patients, 16,947 (3.0%) had a documented AUD diagnosis and 6,080 (1.1%) an OUD diagnosis. Alcohol MAT prescriptions were documented for 547 AUD patients (3.2%) and opioid MAT for 1,764 OUD patients (29.0%). Among OUD patients, opioid MAT was significantly associated with HIV screening (odds ratio [OR] = 1.31, P < .001) in OUD patients, as was alcohol MAT among AUD patients (OR = 1.30, P = .013). Conclusions: These findings suggest that effective opioid and alcohol MAT may be substantially underprescribed among safety-net patients identified as having OUDs or AUDs.